GlassScriptPhysician profile
Carrie A Gordon
NPI 1992772644
$5,103.66
in general payments reported to CMS, 2019-2025
32 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $264 · 2021: $358 · 2022: $3,443 · 2023: $305 · 2024: $228 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.83 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2022 | |
| Abbvie INC. | $335.49 | 2019-2023 | |
| Stryker Corporation | $222.48 | 2022 | |
| Astellas Pharma US INC | $167.17 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $148.74 | 2019-2024 | |
| Hologic Sales and Service, LLC | $120.97 | 2020-2025 | Omni Hysteroscope |
| Exeltis, USA INC. | $111.93 | 2023-2025 | Slynd |
| Organon LLC | $96.30 | 2022-2025 | Nexplanon, Jada System |
| Daiichi Sankyo INC. | $80.95 | 2022 | |
| Myovant Sciences INC. | $74.69 | 2021-2022 | |
| Therapeuticsmd, INC. | $64.18 | 2019-2021 | |
| Baxter Healthcare | $59.76 | 2025 | Perclot |
| Coopersurgical, INC. | $48.86 | 2021-2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $43.27 | 2021-2023 | Phexxi |
| Medtronic, INC. | $39.29 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $38.33 | 2021-2022 | |
| Biogen, INC. | $38.31 | 2025 | Zurzuvae |
| Valencia Technologies Corporation | $37.84 | 2025 | Ecoin Device Kit |
| Pfizer INC. | $37.17 | 2019-2020 | |
| Hologic INC | $35.27 | 2021 | |
| Merck Sharp & Dohme LLC | $34.39 | 2020 | |
| Shield Therapeutics INC | $33.91 | 2025 | |
| Amag Pharmaceuticals, INC. | $32.15 | 2019 | |
| Conmed Corporation | $28.94 | 2024 | Airseal |
| Aspira Women'S Health INC | $25.98 | 2021 | |
| Sumitomo Pharma America, INC. | $25.21 | 2025 | Myfembree |
| Becton, Dickinson and Company | $25.18 | 2024 | Bd Surepath Collection Vial |
| Allergan, INC. | $23.33 | 2020 | |
| Kedrion Biopharma, INC. | $23.11 | 2025 | Rhogam Ultra-Filtered Plus, Albuked, Koate |
| Agile Therapeutics, INC. | $22.25 | 2021 | |
| Channel Medsystems, INC. | $17.82 | 2024 | |
| Meditrina | $10.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.